» Articles » PMID: 2378355

Genetic Epidemiology of Hereditary Tyrosinemia in Quebec and in Saguenay-Lac-St-Jean

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 1990 Aug 1
PMID 2378355
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary tyrosinemia type I is an autosomal recessive disorder that was recognized in Saguenay-Lac-St-Jean (SLSJ) (Quebec) in 1967. Ninety-eight tyrosinemic children, including some of the 113 children born in the SLSJ region, have been screened by the Quebec Network of Genetic Medicine in the whole province since 1970. The geographical distribution of the 98 children screened showed the majority of them to have been born in the northeastern part of Quebec. The prevalence at birth was estimated at 1/1,846 live borns, and the carrier rate was estimated at 1/20 inhabitants in the SLSJ region. Three control groups matched to the tyrosinemic obligate-carrier couples were generated using the population register of the SLSJ region kept at SOREP. The mean coefficient of inbreeding was only slightly elevated in the tyrosinemic group compared with the control groups and was due to remote consanguinity. The mean kinship coefficient was 2.3 times higher in the tyrosinemic group than in the control groups. In the SLSJ region the places of origin of the tyrosinemic children and their parents did not show a clustered nonuniform distribution. Endogamy was not found to be higher in the tyrosinemic group than in the control groups. All these results support both the hypothesis of a founder effect for tyrosinemia and a high gene frequency in northeastern Quebec.

Citing Articles

Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: Consensus group recommendations from the German-speaking countries.

Das A, Ballhausen D, Haas D, Haberle J, Hagedorn T, Janson-Mutsaerts C J Inherit Metab Dis. 2024; 48(1):e12824.

PMID: 39676394 PMC: 11647197. DOI: 10.1002/jimd.12824.


Hereditary tyrosinaemia type 1 in the absence of succinylacetone: 4-oxo 6-hydroxyhepanoate (4OHHA), a putative diagnostic biomarker.

Rehsi P, Witek K, Emmett E, Carling R, Turner C, Dalton N JIMD Rep. 2024; 65(4):255-261.

PMID: 38974614 PMC: 11224492. DOI: 10.1002/jmd2.12436.


Clinical experience with hepatorenal tyrosinemia from a single Egyptian center.

El-Karaksy H, Abdullatif H, Ghobrial C, Mogahed E, Yasin N, Talal N PLoS One. 2022; 17(5):e0268017.

PMID: 35536841 PMC: 9089876. DOI: 10.1371/journal.pone.0268017.


Development of Flow Injection Analysis Method for the Second-Tier Estimation of Succinylacetone in Dried Blood Spot of Newborn Screening.

Varughese B, Madrewar D, Polipalli S, Kapoor S Indian J Clin Biochem. 2022; 37(1):40-50.

PMID: 35125692 PMC: 8799791. DOI: 10.1007/s12291-020-00944-z.


Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study.

Megdadi N, Almigdad A, Alakil M, Alqiam S, Rababah S, Dwiari M Int J Pediatr. 2021; 2021:3327277.

PMID: 34899923 PMC: 8660245. DOI: 10.1155/2021/3327277.


References
1.
Roy R, Bouchard G, Declos M . [The first generation of the Saguenay population: origin, kinship, and rootedness]. Cah Que Demogr. 1988; 17(1):113-34. View

2.
Scriver C, Larochelle J, Silverberg M . Hereditary tyrosinemia and tyrosyluria in a French Canadian geographic isolate. Am J Dis Child. 1967; 113(1):41-6. DOI: 10.1001/archpedi.1967.02090160091008. View

3.
Scriver C, Silverberg M, Clow C . Hereditary tyrosinemia and tyrosyluria: clinical report of four patients. Can Med Assoc J. 1967; 97(18):1047-50. PMC: 1923575. View

4.
Larochelle J, Mortezai A, Belanger M, Tremblay M, CLAVEAU J, Aubin G . Experience with 37 infants with tyrosinemia. Can Med Assoc J. 1967; 97(18):1051-4. PMC: 1923562. View

5.
De Braekeleer M, Smith B . Two methods for measuring the non-randomness of chromosome abnormalities. Ann Hum Genet. 1988; 52(1):63-7. DOI: 10.1111/j.1469-1809.1988.tb01078.x. View